Question

In: Accounting

Amy Dyken, controller at Marigold Pharmaceutical Industries, a public company, is currently preparing the calculation for...

Amy Dyken, controller at Marigold Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Marigold’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020.

Marigold Pharmaceutical Industries
Selected Balance Sheet Information
June 30, 2020

Long-term debt
   Notes payable, 11%

$980,000

   8% convertible bonds payable

5,030,000

   11% bonds payable

6,100,000

     Total long-term debt

$12,110,000

Shareholders’ equity
   Preferred stock, 6% cumulative, $50 par value, 98,000 shares authorized, 24,500 shares issued and outstanding

$1,225,000

   Common stock, $1 par, 10,200,000 shares authorized, 1,020,000 shares issued and outstanding

1,020,000

   Additional paid-in capital

3,940,000

   Retained earnings

6,120,000

     Total shareholders’ equity

$12,305,000


The following transactions have also occurred at Marigold.

1. Options were granted on July 1, 2019, to purchase 220,000 shares at $14 per share. Although no options were exercised during fiscal year 2020, the average price per common share during fiscal year 2020 was $20 per share.
2. Each bond was issued at face value. The 8% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2019.
3. The preferred stock was issued in 2019.
4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2020.
5. The 1,020,000 shares of common stock were outstanding for the entire 2020 fiscal year.
6. Net income for fiscal year 2020 was $1,490,000, and the average income tax rate is 20%.


For the fiscal year ended June 30, 2020, calculate the following for Marigold Pharmaceutical Industries. (Round answers to 2 decimal places, e.g. $2.45.)

(a) Basic earnings per share.

Basic earnings per share

(b) Diluted earnings per share.

Diluted earnings per share

Solutions

Expert Solution


Related Solutions

Amy Dyken, controller at Sheridan Pharmaceutical Industries, a public company, is currently preparing the calculation for...
Amy Dyken, controller at Sheridan Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sheridan’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Sheridan Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% $1,010,000 9% convertible bonds payable 5,090,000 10% bonds payable 6,060,000 Total long-term debt $12,160,000 Shareholders’ equity Preferred stock, 6% cumulative, $50 par...
Amy Dyken, controller at Waterway Pharmaceutical Industries, a public company, is currently preparing the calculation for...
Amy Dyken, controller at Waterway Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Waterway’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Waterway Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt       Notes payable, 10% $990,000 8% convertible bonds payable       5,030,000 10% bonds payable 5,880,000 Total long-term debt $11,900,000         Shareholders’ equity       Preferred...
Question 4 Amy Dyken, controller at Marigold Pharmaceutical Industries, a public company, is currently preparing the...
Question 4 Amy Dyken, controller at Marigold Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Marigold’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2020. Marigold Pharmaceutical Industries Selected Balance Sheet Information June 30, 2020 Long-term debt Notes payable, 10% $1,020,000 8% convertible bonds payable 5,080,000 10% bonds payable 6,110,000 Total long-term debt $12,210,000 Shareholders’ equity Preferred stock, 6% cumulative,...
Problem 16-5 Amy Dyken, controller at Kingbird Pharmaceutical Industries, a public company, is currently preparing the...
Problem 16-5 Amy Dyken, controller at Kingbird Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Kingbird’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2017. KINGBIRD PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 Long-term debt Notes payable, 9% $1,000,000 8% convertible bonds payable 4,910,000 9% bonds payable 6,080,000 Total long-term debt $11,990,000 Shareholders’ equity Preferred stock, 7% cumulative,...
Problem 16-5 Amy Dyken, controller at Ivanhoe Pharmaceutical Industries, a public company, is currently preparing the...
Problem 16-5 Amy Dyken, controller at Ivanhoe Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Ivanhoe’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2017. IVANHOE PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 Long-term debt    Notes payable, 11% $1,010,000    8% convertible bonds payable 5,050,000    11% bonds payable 5,950,000      Total long-term debt $12,010,000 Shareholders’ equity    Preferred stock, 6% cumulative,...
Problem 16-5 Amy Dyken, controller at Buffalo Pharmaceutical Industries, a public company, is currently preparing the...
Problem 16-5 Amy Dyken, controller at Buffalo Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Buffalo’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2017. BUFFALO PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017 Long-term debt Notes payable, 10% $1,000,000 8% convertible bonds payable 5,080,000 10% bonds payable 5,940,000 Total long-term debt $12,020,000 Shareholders’ equity Preferred stock, 6% cumulative,...
Oman Pharmaceutical Industries Co. (OPP) is one of the fastest growing pharmaceutical company in GCC. It...
Oman Pharmaceutical Industries Co. (OPP) is one of the fastest growing pharmaceutical company in GCC. It manufactures four joint products Azithromycin, Clarithromycin, Levofloxacin and Moxifloxacin from a chemical process. After further processing, the company sells Azithromycin, Clarithromycin, Levofloxacin and Moxifloxacin at a price of RO 20, RO 24, RO 16 and RO 12 and estimates a profit of 17.5%, 12.5%, 12.5% and 15% respectively. The costs incurred till the split- off point are RO 39,000. The output achieved at the...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the master budget and has accumulated the following information for 2020. January February March April May Estimated unit sales 10,300 11,600 9,000 8,300 8,000 Sales price per unit $50.30 $48.70 $48.70 $48.70 $48.70 Direct labor hours per unit 2.3 2.3 1.6 1.6 1.6 Wage per direct labor hour $8 $8 $8 $9 $9 Lowell has a labor contract that calls for a wage increase to...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the master budget and has accumulated the following information for 2017. January February March April May Estimated unit sales 10,700 11,000 9,000 8,700 8,900 Sales price per unit $50.60 $47.90 $47.90 $47.90 $47.90 Direct labor hours per unit 2.1 2.1 1.5 1.5 1.5 Wage per direct labor hour $7.00 $7.00 $7.00 $8.00 $8.00 Lowell has a labor contract that calls for a wage increase to...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the...
Lowell Company makes and sells artistic frames for pictures. The controller is responsible for preparing the master budget and has accumulated the following information for 2017. January February March April May Estimated unit sales 12,000 14,000 13,000 11,000 11,000 Sales price per unit $50.00 $47.50 $47.50 $47.50 $47.50 Direct labor hours per unit 2.0 2.0 1.5 1.5 1.5 Wage per direct labor hour $8.00 $8.00 $8.00 $9.00 $9.00 Lowell has a labor contract that calls for a wage increase to...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT